Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
E-7046 is an orally bioavailable and specific EP4 antagonist and exhibits anti-tumor activity. EP4 antagonists reverse PGE2-induced suppression of TNFα production in human whole blood.